JNJ vs VRT: Which Is the Better Buy?
Side-by-side comparison of Johnson & Johnson and Vertiv Holdings Co — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-26.
Johnson & Johnson · Healthcare
$270.68
+5.7% upside to fair value
Med Conviction
Grade C
High Quality
VS
Vertiv Holdings Co · Industrials
$253.28
+8.2% upside to fair value
Med Conviction
Grade C
High Quality
QuantHub Verdict
VRT has more upside to fair value
(+8.2%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
JNJ |
VRT |
| Current Price |
$270.68 |
$253.28 |
| Fair Value Estimate |
$286.05 |
$274.15 |
| Upside to Fair Value |
+5.7%
|
+8.2%
|
| Market Cap |
$652.3B |
$97.5B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
20.2x
|
38.8x
|
| Price / Sales |
6.7x
|
8.5x
|
| Price / FCF |
35.3x
|
33.3x
|
| Revenue Growth YoY |
+6.6%
|
+24.1%
|
| Gross Margin |
67.9%
|
37.5%
|
| Operating Margin |
26.8%
|
19.1%
|
| Return on Equity |
25.7%
|
42.1%
|
| Dividend Yield |
1.95% |
0.1% |
| FCF Yield |
2.83%
|
3.0%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
Johnson & Johnson is a 141,700-employee healthcare holding company operating two segments, Innovative Medicine (immunology, oncology, neuroscience, infectious disease, cardiovascular and metabolism, pulmonary hypertension) and MedTech (interventional solutions, orthopaedics, surgery, vision), founded in 1887 and headquartered in New Brunswick, New Jersey. Business quality is high on fundamentals:…
Vertiv Holdings Co is a global provider of critical digital infrastructure for data centers, communication networks, and industrial applications, spanning AC and DC power management, thermal cooling, integrated rack systems, and lifecycle services under brands including Liebert, NetSure, Geist, and Avocent, with roughly 34,000 employees and a global footprint across the Americas, Asia Pacific, an…
Accumulation Zones
| Metric |
JNJ |
VRT |
| Zone Low |
$214.54 |
$205.61 |
| Zone High |
$243.14 |
$233.03 |
| In Buy Zone? |
No
|
No
|